APA (7th ed.) Citation

O, H., G, J., J, G., J, C., M, G., Z, K., . . . H, S. (2026). Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States. PharmacoEconomics, 44(6), 741. https://doi.org/10.1007/s40273-026-01599-z

Chicago Style (17th ed.) Citation

O, Herrera-Restrepo, et al. "Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States." PharmacoEconomics 44, no. 6 (2026): 741. https://doi.org/10.1007/s40273-026-01599-z.

MLA (9th ed.) Citation

O, Herrera-Restrepo, et al. "Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States." PharmacoEconomics, vol. 44, no. 6, 2026, p. 741, https://doi.org/10.1007/s40273-026-01599-z.